XML 58 R43.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Earnings Per Common Share (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2017
Earnings Per Share [Abstract] |
Computation of Basic and Diluted Earnings per Common Share | The following table sets forth the computation of basic and diluted earnings per common share (in millions, except per share amounts):
| For the Year Ended December 31,
| 2017 |  | 2016 |  | 2015
Basic: |  |  |  |  |
Numerator: |  |  |  |  |
Income from continuing operations | $ | 335.8 |  |  | $ | 318.1 |  |  | $ | 253.7 |
Less: Net income attributable to noncontrolling interests included in continuing operations | (79.1 | ) |  | (70.5 | ) |  | (69.7 | )
Less: Income allocated to participating securities | (0.8 | ) |  | (0.8 | ) |  | (1.0 | )
Less: Convertible perpetual preferred stock dividends | — |  |  | — |  |  | (1.6 | )
Income from continuing operations attributable to Encompass Health common shareholders | 255.9 |  |  | 246.8 |  |  | 181.4 |
Loss from discontinued operations, net of tax, attributable to Encompass Health common shareholders | (0.4 | ) |  | — |  |  | (0.9 | )
Net income attributable to Encompass Health common shareholders | $ | 255.5 |  |  | $ | 246.8 |  |  | $ | 180.5 |
Denominator: |  |  |  |  |  |  |  |
Basic weighted average common shares outstanding | 93.7 |  |  | 89.1 |  |  | 89.4 |
Basic earnings per share attributable to Encompass Health common shareholders: |  |  |  |  |  |  |  |
Continuing operations | $ | 2.73 |  |  | $ | 2.77 |  |  | $ | 2.03 |
Discontinued operations | — |  |  | — |  |  | (0.01 | )
Net income | $ | 2.73 |  |  | $ | 2.77 |  |  | $ | 2.02 |
Diluted: |  |  |  |  |
Numerator: |  |  |  |  |
Income from continuing operations | $ | 335.8 |  |  | $ | 318.1 |  |  | $ | 253.7 |
Less: Net income attributable to noncontrolling interests included in continuing operations | (79.1 | ) |  | (70.5 | ) |  | (69.7 | )
Add: Interest on convertible debt, net of tax | 4.6 |  |  | 9.7 |  |  | 9.4 |
Add: Loss on extinguishment of convertible debt, net of tax | 6.2 |  |  | — |  |  | — |
Income from continuing operations attributable to Encompass Health common shareholders | 267.5 |  |  | 257.3 |  |  | 193.4 |
Loss from discontinued operations, net of tax, attributable to Encompass Health common shareholders | (0.4 | ) |  | — |  |  | (0.9 | )
Net income attributable to Encompass Health common shareholders | $ | 267.1 |  |  | $ | 257.3 |  |  | $ | 192.5 |
Denominator: |  |  |  |  |  |  |  |
Diluted weighted average common shares outstanding | 99.3 |  |  | 99.5 |  |  | 101.0 |
Diluted earnings per share attributable to Encompass Health common shareholders: |  |  |  |  |  |  |  |
Continuing operations | $ | 2.69 |  |  | $ | 2.59 |  |  | $ | 1.92 |
Discontinued operations | — |  |  | — |  |  | (0.01 | )
Net income | $ | 2.69 |  |  | $ | 2.59 |  |  | $ | 1.91 |
Reconciliation of Weighted Average Number of Shares Outstanding | The following table sets forth the reconciliation between basic weighted average common shares outstanding and diluted weighted average common shares outstanding (in millions):
| For the Year Ended December 31,
| 2017 |  | 2016 |  | 2015
Basic weighted average common shares outstanding | 93.7 |  |  | 89.1 |  |  | 89.4 |
Convertible perpetual preferred stock | — |  |  | — |  |  | 1.0 |
Convertible senior subordinated notes | 4.0 |  |  | 8.5 |  |  | 8.3 |
Restricted stock awards, dilutive stock options, and restricted stock units | 1.6 |  |  | 1.9 |  |  | 2.3 |
Diluted weighted average common shares outstanding | 99.3 |  |  | 99.5 |  |  | 101.0 |
Schedule of Warrants | The following table summarizes information relating to these warrants and their activity through their expiration date (number of warrants in millions):
| Number of Warrants |  | Weighted Average Exercise Price
Common stock warrants outstanding as of December 31, 2016 | 8.2 |  |  | $ | 41.40 |
Cashless exercise | (6.5 | ) |  | 41.40 |
Cash exercise | (0.6 | ) |  | 41.40 |
Expired | (1.1 | ) |  | 41.40 |
Common stock warrants outstanding as of January 17, 2017 | — |  |  |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(i)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5047-113901 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section S99 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=68057994&loc=d3e25284-112666 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration